Related references
Note: Only part of the references are listed.Current management and perspectives for HCV recurrence after liver transplantation
Audrey Coilly et al.
LIVER INTERNATIONAL (2013)
A Human monoclonal antibody targeting scavenger receptor class B type I precludes hepatitis C virus infection and viral spread in vitro and in vivo
Philip Meuleman et al.
HEPATOLOGY (2012)
Pharmacokinetic Interaction Between the Hepatitis C Virus Protease Inhibitor Boceprevir and Cyclosporine and Tacrolimus in Healthy Volunteers
Ellen Hulskotte et al.
HEPATOLOGY (2012)
Mycophenolic acid augments interferon-stimulated gene expression and inhibits hepatitis C Virus infection in vitro and in vivo
Qiuwei Pan et al.
HEPATOLOGY (2012)
Immunosuppression and HCV recurrence after liver transplantation
Dimitrios N. Samonakis et al.
JOURNAL OF HEPATOLOGY (2012)
Human Coronavirus-Induced Neuronal Programmed Cell Death Is Cyclophilin D Dependent and Potentially Caspase Dispensable
Dominique J. Favreau et al.
JOURNAL OF VIROLOGY (2012)
Identification of the Niemann-Pick C1-like 1 cholesterol absorption receptor as a new hepatitis C virus entry factor
Bruno Sainz et al.
NATURE MEDICINE (2012)
Association of Cytomegalovirus Infection and Disease With Recurrent Hepatitis C After Liver Transplantation
Wendelyn Bosch et al.
TRANSPLANTATION (2012)
Systematic review: anti-viral therapy of recurrent hepatitis C after liver transplantation
P. Guillouche et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2011)
Interleukin-28B Polymorphisms Are Associated With Histological Recurrence and Treatment Response Following Liver Transplantation in Patients With Hepatitis C Virus Infection
Michael R. Charlton et al.
HEPATOLOGY (2011)
Effect of Telaprevir on the Pharmacokinetics of Cyclosporine and Tacrolimus
Varun Garg et al.
HEPATOLOGY (2011)
An Update on Treatment of Genotype 1 Chronic Hepatitis C Virus Infection: 2011 Practice Guideline by the American Association for the Study of Liver Diseases
Marc G. Ghany et al.
HEPATOLOGY (2011)
Knockdown of Autophagy Enhances the Innate Immune Response in Hepatitis C Virus-Infected Hepatocytes
Shubham Shrivastava et al.
HEPATOLOGY (2011)
Impact of donor and recipient IL28B rs12979860 genotypes on hepatitis C virus liver graft reinfection
Christian M. Lange et al.
JOURNAL OF HEPATOLOGY (2011)
Small molecule scavenger receptor BI antagonists are potent HCV entry inhibitors
Andrew J. Syder et al.
JOURNAL OF HEPATOLOGY (2011)
EGFR and EphA2 are host factors for hepatitis C virus entry and possible targets for antiviral therapy
Joachim Lupberger et al.
NATURE MEDICINE (2011)
Glucocorticosteroids Increase Cell Entry by Hepatitis C Virus
Sandra Ciesek et al.
GASTROENTEROLOGY (2010)
Monoclonal Anti-Claudin 1 Antibodies Prevent Hepatitis C Virus Infection of Primary Human Hepatocytes
Isabel Fofana et al.
GASTROENTEROLOGY (2010)
Inhibition of Hepatitis C Virus Infection by Anti-Claudin-1 Antibodies Is Mediated by Neutralization of E2-CD81-Claudin-1 Associations
Sophie E. Krieger et al.
HEPATOLOGY (2010)
Claudin Association with CD81 Defines Hepatitis C Virus Entry
Helen J. Harris et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
Infectivity of Hepatitis C Virus Is Influenced by Association with Apolipoprotein E Isoforms
Takayuki Hishiki et al.
JOURNAL OF VIROLOGY (2010)
Characterization of the Envelope Glycoproteins Associated with Infectious Hepatitis C Virus
Gabrielle Vieyres et al.
JOURNAL OF VIROLOGY (2010)
Efficacy of boceprevir, an NS3 protease inhibitor, in combination with peginterferon alfa-2b and ribavirin in treatment-naive patients with genotype 1 hepatitis C infection (SPRINT-1): an open-label, randomised, multicentre phase 2 trial
Paul Y. Kwo et al.
LANCET (2010)
Autophagy protein ATG5 interacts transiently with the hepatitis polymerase (NS5B) early during infection
Carl Guevin et al.
VIROLOGY (2010)
Amphipathic DNA Polymers Inhibit Hepatitis C Virus Infection by Blocking Viral Entry
Takuya Matsumura et al.
GASTROENTEROLOGY (2009)
Antiviral therapy increases the risk of bacterial infections in HCV-infected cirrhotic patients awaiting liver transplantation: A retrospective study
Jose A. Carrion et al.
JOURNAL OF HEPATOLOGY (2009)
Hepatoma Cell Density Promotes Claudin-1 and Scavenger Receptor BI Expression and Hepatitis C Virus Internalization
Anne K. Schwarz et al.
JOURNAL OF VIROLOGY (2009)
Human occludin is a hepatitis C virus entry factor required for infection of mouse cells
Alexander Ploss et al.
NATURE (2009)
Genetic variation in IL28B predicts hepatitis C treatment-induced viral clearance
Dongliang Ge et al.
NATURE (2009)
Genetic variation in IL28B and spontaneous clearance of hepatitis C virus
David L. Thomas et al.
NATURE (2009)
IL28B is associated with response to chronic hepatitis C interferon-α and ribavirin therapy
Vijayaprakash Suppiah et al.
NATURE GENETICS (2009)
Telaprevir and Peginterferon with or without Ribavirin for Chronic HCV Infection
Christophe Hezode et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Telaprevir with Peginterferon and Ribavirin for Chronic HCV Genotype 1 Infection
John G. McHutchison et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Transplantation in the patient with hepatitis C
Beatriz Dominguez-Gil et al.
TRANSPLANT INTERNATIONAL (2009)
Molecular and Cellular Aspects of Hepatitis C Virus Reinfection After Liver Transplantation: How the Early Phase Impacts on Outcomes
Geoffrey W. McCaughan et al.
TRANSPLANTATION (2009)
Anti-CD81 Antibodies Can Prevent a Hepatitis C Virus Infection In Vivo
Philip Meuleman et al.
HEPATOLOGY (2008)
Host neutralizing responses and pathogenesis of hepatitis C virus infection
Mirjam B. Zeisel et al.
HEPATOLOGY (2008)
Induction of incomplete autophagic response by hepatitis C virus via the unfolded protein response
Donna Sir et al.
HEPATOLOGY (2008)
Systematic review of the treatment of established recurrent hepatitis C with pegylated interferon in combination with ribavirin
Marina Berenguer
JOURNAL OF HEPATOLOGY (2008)
Pegylated-interferon and ribavirin in liver transplant candidates and recipients with HCV cirrhosis: systematic review and meta-analysis of prospective controlled studies
E. Xirouchakis et al.
JOURNAL OF VIRAL HEPATITIS (2008)
CD81 and claudin 1 coreceptor association: Role in hepatitis C virus entry
Helen J. Harris et al.
JOURNAL OF VIROLOGY (2008)
Steroid avoidance in liver transplantation: Meta-analysis and meta-regression of randomized trials
Dorry L. Segev et al.
LIVER TRANSPLANTATION (2008)
Effect of pretransplant hepatitis C virus RNA status on posttransplant outcome
C. G. Nudo et al.
TRANSPLANTATION PROCEEDINGS (2008)
Hepatitis C virus receptor expression in normal and diseased liver tissue
Gary M. Reynolds et al.
HEPATOLOGY (2008)
Broadly neutralizing antibodies protect against hepatitis C virus quasispecies challenge
Mansun Law et al.
NATURE MEDICINE (2008)
Influence of steroids on HCV recurrence after liver transplantation: A prospective study
Marco Vivarelli et al.
JOURNAL OF HEPATOLOGY (2007)
Risk factors for hepatitis C recurrence after liver transplantation
B. Roche et al.
JOURNAL OF VIRAL HEPATITIS (2007)
Characterization of fusion determinants points to the involvement of three discrete regions of both E1 and E2 glycoproteins in the membrane fusion process of hepatitis C virus
Dirnitri Lavillette et al.
JOURNAL OF VIROLOGY (2007)
High-avidity monoclonal antibodies against the human scavenger class B type I receptor efficiently block hepatitis C virus infection in the presence of high-density lipoprotein
Maria Teresa Catanese et al.
JOURNAL OF VIROLOGY (2007)
Efficacy of antiviral therapy on hepatitis C recurrence after liver transplantation:: A randomized controlled study
Jose A. Carrion et al.
GASTROENTEROLOGY (2007)
Claudin-1 is a hepatitis C virus co-receptor required for a late step in entry
Matthew J. Evans et al.
NATURE (2007)
Rapid induction of virus-neutralizing antibodies and viral clearance in a single-source outbreak of hepatitis C
Jan M. Pestka et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
Exploring the bidirectional interactions between human cytomegalovirus and hepatitis C virus replication after liver transplantation
Gaia Nebbia et al.
LIVER TRANSPLANTATION (2007)
Mycophenolic acid inhibits hepatitis C virus replication and acts in synergy with cyclosporin A and interferon-α
Scot D. Henry et al.
GASTROENTEROLOGY (2006)
Prednisolone suppresses the function and promotes apoptosis of plasmacytoid dendritic cells
P. P. C. Boor et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2006)
Effect of nonviral factors on hepatitis C recurrence after liver transplantation
Andrew M. Cameron et al.
ANNALS OF SURGERY (2006)
Identification of conserved residues in the E2 envelope glycoprotein of the hepatitis C virus that are critical for CD81 binding
Ania M. Owsianka et al.
JOURNAL OF VIROLOGY (2006)
Entry of hepatitis C virus pseudotypes into primary human hepatocytes by clathrin-dependent endocytosis
Audrey Codran et al.
JOURNAL OF GENERAL VIROLOGY (2006)
Monoclonal antibody HCV-AbXTL68 in patients undergoing liver transplantation for HCV:: Results of a phase 2 randomized study
Thomas D. Schiano et al.
LIVER TRANSPLANTATION (2006)
Interferon-based combination anti-viral therapy for hepatitis C virus after liver transplantation: A review and quantitative analysis
C. S. Wang et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2006)
Hepatitis C virus entry depends on clathrin-mediated endocytosis
Emmanuelle Blanchard et al.
JOURNAL OF VIROLOGY (2006)
Different domains of CD81 mediate distinct stages of hepatitis C virus pseudoparticle entry
Claire Bertaux et al.
JOURNAL OF VIROLOGY (2006)
Living donor liver transplantation for hepatitis C-related cirrhosis: No difference in histological recurrence when compared to deceased donor liver transplantation recipients
LS Guo et al.
LIVER TRANSPLANTATION (2006)
Hepatitis C virus glycoproteins mediate low pH-dependent membrane fusion with liposomes
D Lavillette et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
Time- and temperature-dependent activation of hepatitis C virus for low-pH-triggered entry
DM Tscherne et al.
JOURNAL OF VIROLOGY (2006)
Kinetics of hepatitis C virus reinfection after liver transplantation
KA Powers et al.
LIVER TRANSPLANTATION (2006)
The interaction of natural hepatitis C virus with human scavenger receptor SR-BI/Cla1 is mediated by ApoB-containing lipoproteins
Patrick Maillard et al.
FASEB JOURNAL (2006)
Suppression of hepatitis C virus replication by cyclosporin A is mediated by blockade of cyclophilins
M Nakagawa et al.
GASTROENTEROLOGY (2005)
Treatment of advanced hepatitis C with a low accelerating dosage regimen of antiviral therapy
GT Everson et al.
HEPATOLOGY (2005)
A randomized, open-label study to evaluate the safety and pharmacokinetics of human hepatitis C immune globulin (Civacir) in liver transplant recipients
GL Davis et al.
LIVER TRANSPLANTATION (2005)
Cyclophilin B is a functional regulator of hepatitis C virus RNA polymerase
K Watashi et al.
MOLECULAR CELL (2005)
Is triple vs. dual drug therapy associated with increased risk of death due to malignancy in adult liver transplant recipients?
JR Lake et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2005)
Differential effects of donor age in liver transplant recipients infected with hepatitis B, hepatitis C and without viral hepatitis
JR Lake et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2005)
Peginterferon alfa-2a for hepatitis C after liver transplantation: Two randomized, controlled trials
N Chalasani et al.
HEPATOLOGY (2005)
Applicability, tolerability and efficacy of preemptive antiviral therapy in hepatitis C-infected patients undergoing liver transplantation
AK Shergill et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2005)
Mechanisms of HCV reinfection and allograft damage after liver transplantation
GW McCaughan et al.
JOURNAL OF HEPATOLOGY (2004)
Hepatitis C recurrence is more severe after living donor compared to cadaveric liver transplantation
M Garcia-Retortillo et al.
HEPATOLOGY (2004)
Diverse hepatitis C virus glycoproteins mediate viral infection in a CD81-dependent manner
JA McKeating et al.
JOURNAL OF VIROLOGY (2004)
Preemptive therapy for hepatitis C virus after living-donor liver transplantation
Y Sugawara et al.
TRANSPLANTATION (2004)
Cell entry of hepatitis C virus requires a set of co-receptors that include the CD81 tetraspanin and the SR-B1 scavenger receptor
B Bartosch et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Small molecule inhibition of hepatitis C virus E2 binding to CD81
SE VanCompernolle et al.
VIROLOGY (2003)
The human scavenger receptor class B type I is a novel candidate receptor for the hepatitis C virus
E Scarselli et al.
EMBO JOURNAL (2002)
Natural history of recurrent hepatitis C
M Berenguer
LIVER TRANSPLANTATION (2002)
Analysis of antigenicity and topology of E2 glycoprotein present on recombinant hepatitis C virus-like particles
RF Clayton et al.
JOURNAL OF VIROLOGY (2002)
Contribution of donor age to the recent decrease in patient survival among HCV-infected liver transplant recipients
M Berenguer et al.
HEPATOLOGY (2002)
Interactions between cytomegalovirus, human herpesvirus-6, and the recurrence of hepatitis C after liver transplantation
A Humar et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2002)
Impact of human herpesvirus-6 on the frequency and severity of recurrent hepatitis C virus hepatitis in liver transplant recipients
N Singh et al.
CLINICAL TRANSPLANTATION (2002)
The association between hepatitis C infection and survival after orthotopic liver transplantation
LM Forman et al.
GASTROENTEROLOGY (2002)
Timing of reinfection and mechanisms of hepatocellular damage in transplanted hepatitis C virus-reinfected liver
G Ballardini et al.
LIVER TRANSPLANTATION (2002)
Hepatitis C virus kinetics during and immediately after liver transplantation
M Garcia-Retortillo et al.
HEPATOLOGY (2002)
Scavenger receptor class B type I is a multiligand HDL receptor that influences diverse physiologic systems
M Krieger
JOURNAL OF CLINICAL INVESTIGATION (2001)
Prevention of recurrent hepatitis C after liver transplantation with early interferon and ribavirin treatment
V Mazzaferro et al.
TRANSPLANTATION PROCEEDINGS (2001)
Characterization of hepatitis C virus (HCV) and HCV E2 interactions with CD81 and the low-density lipoprotein receptor
S Wünschmann et al.
JOURNAL OF VIROLOGY (2000)
Early detection of hepatitis C allograft reinfection after orthotopic liver transplantation: A molecular and histologic study
RB Guerrero et al.
MODERN PATHOLOGY (2000)
Share Paper
